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INTRODUCTION 
Hepcidin is a one of the factors that most recently has been 
recognized and plays an important role in the regulation of 
erythropoiesis. It is a small peptide hormone which is cysteine-
rich and is mostly secreted by hepatic cells. Hepcidin plays a vital 
role in constant maintenance of iron homeostasis in the human 
body. Its identification at the beginning of the new millennium 
has brought a new perspective on the understanding of the 
iron metabolism. Hepcidin controls absorption of dietary iron by 
connecting to enterocytes of duodenal. In addition, by connecting 
to macrophages, it inhibits the release of iron. Intestinal iron 
absorption, iron uptake, and its release from cell resources and 
finally haematopoiesis is controlled by hepcidin [1,2]. It has been 
demonstrated that removal of hepcidin gene can cause severe 
forms of iron overload disease [3]. On the contrary, high expression 
of hepcidin results in the decrease of iron absorption and iron 
deficiency anaemia [4].
One of the most important inducers of hepcidin expression is 
chronic inflammation which can lead to anaemia [5]. The treatment 
of anaemia caused by chronic inflammation is an important emerg-
ency for the patients with this condition. It has been proven that 
increased expression of hepcidin plays an important role in the 
development of anaemia in patients with chronic inflammation [6]. 
One of the medicinal herbs that have potent anti-inflammatory effects 
is Andrographis paniculata. This plant is the acanthaceae family that 
contains diterpanes, lactones and flavonoids. Andrographolide is 
the most effective isolated agent from Andrographis paniculata. It 
has been shown that androgrophloide has a very effective role in 
inhibiting inflammatory processes and increase the expression of 
heme oxygenase 1, and in this way, it interferes with iron recycling 
[7-10]. In this study, we hypothesized that iron overload would 
increase hepatic hepcidin expression, so we examined the effect of 
andrographolide on hepatic hepcidin expression.
MATERIALS AND METHODS
The present experimental study was conducted with permission 
from the Animal Ethics Committee of Ardabil University of 
Medical Sciences, in December 2016 (Ethical code: IR.ARUMS.
REC.1394.125). In this study, 48 adult male Wistar strain rats 
weighing approximately 100-150 g were used. The rats were kept 
in standard conditions of temperature and food.
The rats were randomly divided into six groups of eight: 1) The 
control group (receiving 1 cc of physiologic serum as intraperitoneal 
injection); 2) receiving iron sucrose group (75 mg/kg body weight); 
3) receiving 3.5 mg/kg andrographolide group; 4) receiving 7 mg/kg 
andrographolide group; 5) receiving iron sucrose 75 mg/kg plus 3.5 
mg/kg andrographolide group; and 6) receiving iron sucrose 75 mg/
kg plus 7 mg/kg andrographolide group. To creating iron overload, 
iron receiving groups received iron sucrose (Venofer-Germany) for 
two weeks with a dose of 75 mg per kilogram of body weight. 
Andrographolide was purchased in the form of powder from Sigma 
Company (365645-100MG). It was prepared in PBS solution at 
concentrations of 3.5 and 7 mg and was injected intraperitoneal in a 
volume of 1 ml. The experimental period to create iron overload was 
six days. After the sixth day, the rats were anesthetized and blood 
samples were taken from the heart and then they were killed. Then, 
their livers were removed and cut into smaller pieces and were kept 
in Falcon tubes at -80°C until the experiment.
Tissue samples were also fixed in 10% formalin for histology. Liver 
samples were embedded in paraffin for staining to examine iron 
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ABSTRACT
Introduction: Hepcidin is the most important factor in iron 
metabolism and plays a potential role in erythropoiesis. It is a small 
peptide hormone which is cysteine-rich and is mostly secreted by 
hepatic cells. 
Aim: The purpose of this study was to evaluate the effect of 
andrographolide on the expression of hepatic hepcidin in an iron 
overload model.
Materials and Methods: For the current study, 48 male Wistar 
rats were used in six groups. These groups included control 
group, andrographolide with 3.5 and 7 mg/kg doses groups, iron 
plus andrographolide groups with 3.5 and 7 mg/kg doses, and 
iron group. Hepcidin gene expression was performed by real-time 
method. Iron serum levels were measured by photometry. We 
used ANOVA and Kruskal Wallis to compare the means of the 
factors under investigation.
Results: The results revealed that the quantitative expression 
levels of mRNA hepcidin decreased in all groups except in 
iron group compared with the control group. This decrease in 
andrographolide 7 mg/kg, iron plus andrographolide 3.5 mg/kg, 
and iron plus andrographolide 7 mg/kg groups was significant 
compared with the control group (p<0.05). The quantitative 
expression level of mRNA hepcidin significantly increased in iron 
group compared with the control group (p<0.05). The findings 
also indicated that serum concentration of iron in groups with 
secondary iron overload significantly increased compared with the 
control group (p<0.05). 
Conclusion: Andrographolide with 3.5 and 7 mg/kg doses 
decreases the expression of hepcidin and increases iron serum 
levels in secondary iron overload model.
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deposition. Slides were mounted with 4 µm sections stained with 
haematoxylin & eosin, and examined by light microscopy by an 
experienced pathologist. To extract RNA from the hepatic tissue, 
Trizol (Thermo Fisher Scientific, USA) was used. In this method, 100 
mg of hepatic tissue was homogenized, and then 1000 µl Trizol was 
added. To separate the RNA from protein and DNA phases, the 
chloroform solution was used. To precipitate the RNA, a solution of 
isopropanol was employed. All the equipment and materials were 
RNAse Free. RNA quality and quantity were measured using the 
NanoDrop spectrophotometer (Thermo Scientific- USA) and RNA 
integrity was determined by gel electrophoresis. To ensure that there 
was no contamination of the RNA, DNAse I enzyme was employed. 
In this method, 1 µl of the extracted RNA was mixed with 1 µl buffer 
of TBE 10X and 0.5 µl of DNase I (1u/µl), and the final volume was 
brought to 10 µl using RNAse Free DEPC water. Then the samples 
were kept for 30 minutes at 37°C. Then about 1 µl of EDTA 50 mM 
was added to all samples and it was incubated for 10 minutes at 
65°C. For the synthesis of cDNA from the extracted RNA, Sina Gen 
standard kit (RT-5201) was employed. To prepare Master mix for 
the Real-time PCR reaction of hepcidin and GAPDH genes, 12.5 
µl SYBR green, 0.5 µl forward primer, 0.5 µl reverse primer, and 1 
µl cDNA were mixed together. The final volume with Nuclease free 
water (NF water) was brought to 20 µl. The temperature cycle was 
set as follows: First 10 minutes at 95°C, followed by 40 cycles at 
94°C for 30 seconds, 30 seconds at 60°C, 30 seconds at 72°C, 10 
seconds at 95°C, 60 seconds at 65°C, 1 second at 97°C, and 30 
seconds at 37°C. Primers of [Table/Fig-1] were used for the Real-
time PCR of hepcidin and GAPDH (as controller) genes. Serum 
iron levels were measured using a standard kit and photometry 
method.
Real-time PCR data analysis was conducted using 2-ΔΔCT method. 
In this method, the rate of change in hepcidin gene expression was 
calculated using GAPDH gene as the reference gene. 
Data Analysis
We used ANOVA and Kruskal Wallis (SPSS Ver. 16) to compare the 
means of the factors under investigation. The level of significance 
was set at p<0.05.
RESULTS 
The results revealed that the quantitative expression levels of mRNA 
hepcidin decreased in all groups except in iron group compared with 
the control group [Table/Fig-2]. This decrease in andrographolide 
7 mg/kg, iron plus andrographolide 3.5 mg/kg, and iron plus 
andrographolide 7 mg/kg groups was significant compared with the 
control group (p<0.05). The quantitative expression level of mRNA 
hepcidin significantly increased in iron group compared with the 
control group (p<0.05).
The findings also indicated that serum concentration of iron in 
groups with secondary iron overload significantly increased com-
pared with the control group (p<0.05) [Table/Fig-3]. Increased serum 
levels of iron in the iron plus andrographolide 7 mg/kg and iron plus 
andrographolide 3.5 mg/kg groups were more significant. Hepatic 
tissue samples of rats with iron overload compared with the control 
group have been shown in [Table/Fig-4]. The results of the melting 
curve for hepcidin gene in different groups have been shown in 
[Table/Fig-5]. The results of the threshold cycle for hepcidin gene in 
different groups have been given in [Table/Fig-6].
[Table/Fig-1]: The sequences of primers in hepcidin and GAPDH genes.
gene
Forward primer 
(5’ → 3’)
reverse primer 
(5’ → 3’) tm (°C)
amplicon  
size (bp)
Hepcidin AAGATGGCACTA GCATTTACAGCA 60 219
GAPDH GTTACCAGGGCT GGGTTTCCCGTT 60 110
[Table/Fig-4]: Hepatic tissue samples in control group (a) and rats with iron over-
load (b). 
* The arrows show iron deposition.
DISCUSSION 
The results of our findings revealed that the quantitative expression 
levels of mRNA hepcidin decreased in all groups except in iron group 
compared with the control group. Hepcidin is one of the hormones 
that have recently attracted the attention of many researchers. As 
[Table/Fig-5]: The melting curve of hepcidin gene in different studied groups.
[Table/Fig-2]: Comparison of hepcidin gene expression levels in different studied 
groups.
* Existence of statistically significant difference compared with the control group (p<0.05)
[Table/Fig-3]: Mean serum iron concentration in control and different studied groups.
** Existence of statistically significant difference compared with the control group (p<0.001)
www.jcdr.net Vadoud Malekzadeh et al., Andrographolide, A Novel Repressor of Hepcidin Gene Expression
Journal of Clinical and Diagnostic Research. 2018 May, Vol-12(5): BF01-BF04 3
the main regulator of iron distribution and by controlling ferroportin 
on the surface of intestinal cells and macrophages, it limits the 
supply of iron for haematopoiesis. In addition to its effect on reducing 
iron supply for haematopoiesis, it also has some inhibitory effects 
on haematopoiesis of the bone marrow [5,11,12]. Hepcidin also 
decreases the proliferation and the survival of progenitor red blood 
cells [13]. Increasing in hepcidin serum levels is considered as one 
of the main causes of anaemia and a decrease in hemoglobin levels 
in patients with chronic inflammation [14]. Since curing anaemia in 
these patients is one of the medical priorities [15,16], so investigating 
the factors that affect hepcidin expression is necessary. In this 
study, we have tried to create a model of secondary iron overload 
as hepatic hepcidin expression inducer to investigate the effect of 
andrographolide on enhanced hepatic hepcidin expression. We 
showed that andrographolide can inhibit expression levels of mRNA 
hepcidin in iron overload animal model. Therefore, andrographolide 
can be used to improve the anaemia of inflammatory diseases.
In our study, by injecting iron sucrose, the quantitative hepcidin 
mRNA expression in iron overload group significantly increased 
compared with the control group. This finding was in accordance 
with several other related studies [17,18]. It has been demonstrated 
that increased expression of hepcidin is considered body’s defense 
mechanism to prevent the intestinal iron absorption and iron overload 
in the body [18]. In our study, decreased hepatic hepcidin mRNA 
expression was observed in all injected groups with andrographolide 
at doses of 3.5 and 7 mg/kg compared with the control and iron 
groups. Reduced hepcidin expression by andrographolide injection 
in groups with secondary iron overload was much higher than those 
who were just affected by andrographolide without secondary iron 
overload. Basically, the existence of iron overload is resulting in 
increased hepcidin expression compared with samples without iron 
overload [19]. Our results also confirmed this finding and showed 
that hepcidin expression levels had strong relationship with iron 
serum levels. As with reduced expression of hepcidin levels resulted 
in increasing serum iron levels. In iron overload groups affected 
by andrographolide increasing in iron serum levels was more than 
just iron overload group. It can be caused by reduced expression 
of hepcidin in these groups. Andrographolide is a diterpene 
combination extracted from the Andrographis paniculata plant [20]. 
In most studies, anti-inflammatory and antioxidant effects of andro-
grapholide have been investigated. Studies have revealed that 
andrographolide inhibits the production of inflammatory markers of IL-
12, TNF-α, NF-κB, iNOS and COX-2 in macrophages. Furthermore, 
andrographolide inhibits the inflammatory process through covalent 
binding to the transcription factor of NF-kB and by forming complex 
with NF-kB prevents it from binding to DNA [21-24]. There is little 
research regarding the effects of andrographolide on the expression 
of some genes. It has been shown that andrographolide by reducing 
the synthesis and the stability of nitric oxide synthase inhibits this 
enzyme in post-translational processes [22]. Also, andrographolide 
or its derivatives can increase the expression of CYP1A1, CYP1A2 
and CYP1B1 genes, but decrease the expression of TNF [23,25]. 
In addition, andrographolide with intracellular increasing of NRF2, 
can increase the expression of heme oxygenase 1, and in this way, 
it interferes with iron recycling [9,10]. According to many studies, 
andrographolide inhibits the expression of IL-6 as one of the most 
important markers of inflammation [26-28]. Since IL-6 is one of the 
most important stimuli in hepcidin production, so increase in the 
amount of IL-6 in chronic inflammatory conditions can increase 
the production of hepcidin [29,30]. Therefore, andrographolide by 
inhibiting the production of IL-6 reduce the production of hepcidin. 
In our study, probably a total of factors such as andrographolide 
effects in reducing the inflammatory process, or its effect on 
hepcidin expression via IL-6 or its impact on the processes of post-
translational protein have been involved. Our study is the first step 
in andrographolide effects on hepcidin gene expression and more 
research should be done in this field. 
CONCLUSION 
Andrographolide at doses of 3.5 and 7 mg/kg reduces hepcidin 
expression and increases serum levels of iron in secondary iron 
overload model.
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